Clinical Trial Update: An Observational Study of Patients With Moderate Parkinson's Disease

View source ↗

Summary

This is an observational study enrolling patients with moderate Parkinson's disease to collect real-world data. It is sponsored by Novo Nordisk A/S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Parkinson Disease | Status: ENROLLING_BY_INVITATION